OAC
STOK icon

OMERS Administration Corp’s Stoke Therapeutics STOK Stock Holding History

OMERS Administration Corp’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982K Sell
30,000
-11,500
-28% -$369K 0.01% 707
2026
Q1 		$1.35M Buy
+41,500
New +$1.36M 0.01% 595
2025
Q4 		– Sell
-12,100
Closed -$284K – 1317
2025
Q3 		$284K Buy
+12,100
New +$207K ﹤0.01% 896

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OMERS Administration Corp's STOK Position: Q2 2026 in Review

OMERS Administration Corp reduced its Stoke Therapeutics (STOK) stake by 28% in Q2 2026, selling an estimated $369K and leaving 30,000 shares worth $982K. The position accounts for 0.01% of the portfolio, ranked #707.

OMERS Administration Corp first reported a position in STOK in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.35M in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • OMERS Administration Corp held 30,000 shares of Stoke Therapeutics worth $982K as of Q2 2026.
  • OMERS Administration Corp sold 11,500 Stoke Therapeutics shares in Q2 2026, an estimated $369K.
  • Stoke Therapeutics made up 0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #707 holding.
  • OMERS Administration Corp first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • OMERS Administration Corp's Stoke Therapeutics position peaked at $1.35M in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.